UNSPSC 51283307: Tedizolid

A type of antibacterial drug indicated for treatment of acute bacterial skin and skin structure infections by susceptible bacteria.

UNSPSC 51283307 Tedizolid is a Commodity code that represents a specific pharmaceutical product — an oxazolidinone antibiotic — but the recent state and local opportunities tagged under this code do not reflect procurement of tedizolid itself. Instead, the posted solicitations document purchases of other pharmaceuticals (doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone) and medical devices (safe drug deactivation systems) through state and county health agencies. The code shows little relevant recent activity aligned with its nominal scope. State and local health departments and county health authorities are the primary issuing bodies when pharmaceutical procurement appears under this taxonomy, typically sourcing through cooperative purchasing vehicles such as MMCAP Infuse or direct competitive bidding for emergency preparedness and community health support.

Recent opportunities include the Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse contract through MMCAP Infuse awarded to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride totaling $2,999,999.11 over 12 months with renewal options, and Seminole County, Florida's June 2026 IFB for naloxone and safe drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually) with quarterly deliveries required to the Seminole County Community Health Building in Sanford. Activity appears concentrated in Florida and Illinois, though the mismatch between the code's nominal scope (tedizolid) and the products actually solicited limits the utility of this category for targeted pursuit.